featured
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Addendum to ICH M7 on Risk Assessment and Control of N-Nitrosamine Impurities |
|
7 | 648 | May 30, 2025 |
| 📖 Drug Substance and Drug Product Workflows for Quality Risk Management for the Presence of Nitrosamines in Medicines-Pub |
|
2 | 257 | May 27, 2025 |
| What if the answer you’re looking for is already here, with someone in this community? |
|
7 | 643 | May 27, 2025 |
| FDA Generic Drugs Forum - Bioequivalence Approaches |
|
2 | 515 | April 22, 2025 |
| Nitrosamines: Mass Spectrometry-Based Analytical Procedures Criterias |
|
6 | 3287 | April 22, 2025 |
| Modeling the Impact of Excipients Selection on Nitrosamine Formation towards Risk Mitigation |
|
17 | 4384 | January 10, 2025 |